CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Bausch + Lomb outlines 2026 revenue of $5.440B-$5.540B and adjusted EBITDA of $1.025B-$1.075B as cash flow accelerates

EarningsPositive
AI Analysis

Summary

Bausch + Lomb provided 2026 revenue guidance of $5.440B-$5.540B and adjusted EBITDA guidance of $1.025B-$1.075B with accelerating cash flow.

Financial Highlights

Revenue

$5.440B-$5.540B

Guidance

2026 revenue guidance of $5.440B-$5.540B and adjusted EBITDA of $1.025B-$1.075B

Importance:4/10
Sentiment:
0.50
guidanceearningsrevenue forecastEBITDA
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 30, 2026 7:44 AM

Read Original